| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Jean-Pierre Boissel | |
| Michel Cucherat | |||
| Nirav R Shah | |||
| Alain Leizorovicza | |||
| Behrouz Kassaï | |||
| Francois Gueyffier | |||
| P2860 | cites work | Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation | Q28204445 |
| Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative | Q30447885 | ||
| Calf deep venous thrombosis. A wolf in sheep's clothing? | Q30461530 | ||
| Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review | Q30764308 | ||
| Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: implications for the interpretation and design of thromboprophylaxis trials | Q72338910 | ||
| Comparison of a screening test and a reference test in epidemiologic studies. I. Indices of agreement and their relation to prevalence | Q72835589 | ||
| Comparison of a screening test and a reference test in epidemiologic studies. II. A probabilistic model for the comparison of diagnostic tests | Q72835590 | ||
| Prevention of venous thromboembolism | Q73396742 | ||
| Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty--a meta-analysis | Q73926591 | ||
| [Clinical evaluation: from intermediate to surrogate criteria] | Q74073006 | ||
| Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes | Q74387197 | ||
| Are symptomatic endpoints acceptable in venous thromboprophylactic studies? | Q74590375 | ||
| Phlebographic patterns of acute deep venous thrombosis of the leg | Q76481336 | ||
| How "gold" is the standard? Interobservers' variation on venograms | Q77354655 | ||
| Prevalence of deep vein thrombosis in suspected and proven pulmonary embolism: a meta-analysis | Q77726859 | ||
| Natural history of postoperative deep-vein thrombosis | Q93739142 | ||
| Thromboprophylaxis and death after total hip replacement | Q95793127 | ||
| Empirical evidence of design-related bias in studies of diagnostic tests | Q30776370 | ||
| Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review | Q31145108 | ||
| Designing studies to ensure that estimates of test accuracy are transferable | Q33809569 | ||
| Natural history of venous thromboembolism | Q34207019 | ||
| Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations | Q34342972 | ||
| Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop | Q34386133 | ||
| Evaluation of diagnostic procedures | Q34540929 | ||
| Exploring sources of heterogeneity in systematic reviews of diagnostic tests | Q34733068 | ||
| The assessment of deep vein thromboses for therapeutic trials. | Q35068757 | ||
| The epidemiology of venous thromboembolism. | Q35157791 | ||
| Surrogate endpoints: a basis for a rational approach | Q35488355 | ||
| Evaluating diagnostic tests with imperfect standards | Q38140577 | ||
| Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery | Q39638109 | ||
| Use of methodological standards in diagnostic test research. Getting better but still not good. | Q40461184 | ||
| Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. | Q40570127 | ||
| Meta-analytic methods for diagnostic test accuracy | Q40590958 | ||
| Surrogate end points in clinical trials: are we being misled? | Q41117631 | ||
| Surrogate endpoints in clinical trials: definition and operational criteria | Q41310696 | ||
| Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: a clinical example | Q41442549 | ||
| Is embolic risk conditioned by location of deep venous thrombosis? | Q41471815 | ||
| Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge | Q41682626 | ||
| The architecture of diagnostic research | Q41829431 | ||
| Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials | Q43674942 | ||
| Mortality and fatal pulmonary embolism after primary total hip replacement. Results from a regional hip register | Q44907974 | ||
| Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients | Q45004028 | ||
| Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty | Q46788662 | ||
| Assessment of the accuracy of diagnostic tests: the cross-sectional study. | Q47387853 | ||
| Meta-analysis of diagnostic tests with imperfect reference standards. | Q52142845 | ||
| Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. | Q52264482 | ||
| Causal modeling to estimate sensitivity and specificity of a test when prevalence changes. | Q52284501 | ||
| Potential influence of observer variation in thromboprophylactic trials. | Q52860760 | ||
| The influence of referral patterns on the characteristics of diagnostic tests | Q52860830 | ||
| Reliability of phlebography in the assessment of venous thrombosis in a clinical trial. | Q52863955 | ||
| Venography in deep venous thrombosis: postoperative screening of patients in prophylaxis studies. | Q52885359 | ||
| 125I-fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients. | Q52885819 | ||
| Accuracy of sonography in the evaluation of calf deep vein thrombosis in both postoperative surveillance and symptomatic patients. | Q52887568 | ||
| Triplex US in the diagnosis of asymptomatic deep venous thrombosis. | Q52893494 | ||
| A systematic review of the accuracy of ultrasound in the diagnosis of deep venous thrombosis in asymptomatic patients. | Q52961008 | ||
| Factors affecting sensitivity and specificity of exercise electrocardiography | Q56928628 | ||
| A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients | Q57311991 | ||
| Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures | Q57317303 | ||
| The logistic modeling of sensitivity, specificity, and predictive value of a diagnostic test | Q67749910 | ||
| Long-term clinical observations and venous functional abnormalities after asymptomatic venous thrombosis following total hip or knee arthroplasty | Q68410064 | ||
| Reverend Bayes' silent majority. An alternative factor affecting sensitivity and specificity of exercise electrocardiography | Q69611308 | ||
| The effect of conditional dependence on the evaluation of diagnostic tests | Q69785669 | ||
| An effect model for the assessment of drug benefit: example of antiarrhythmic drugs in postmyocardial infarction patients | Q71599929 | ||
| The origin of deep vein thrombosis: a venographic study | Q71822453 | ||
| Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research | Q72099581 | ||
| Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration | Q72114851 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1042-1051 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Journal of Clinical Epidemiology | Q6294959 |
| P1476 | title | The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests | |
| P478 | volume | 58 |
| Q51896797 | Evidence-based mechanistic reasoning. |
| Q27003914 | Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes? |
| Q81235293 | Prevention of venous thromboembolism in patients with stroke--enoxaparin vs unfractionated heparin |
| Q38753960 | SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis |
| Q38590481 | Statistical approaches for evaluating surrogate outcomes in clinical trials: A systematic review. |
| Q33961751 | The application of biomarkers in clinical trials for motor neuron disease |
| Q81298331 | Trials of venous thromboembolism prevention |
Search more.